Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9205628 | 0.81 | TSHR (0.40) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL28211136 | 0.79 | LPAR3 (0.47) | PPARDTSHRTDP1LPAR1LPAR3 | |
| SCHEMBL4459814 | 0.78 | TSHR (0.42) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL13986850 | 0.77 | — | — | |
| SCHEMBL4486615 | 0.77 | — | — | |
| SCHEMBL13986844 | 0.77 | — | — | |
| SCHEMBL2994641 | 0.77 | CA12 (0.48) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL10889980 | 0.75 | TSHR (0.43) | PPARDTSHRTP53TDP1CA12 | |
| SCHEMBL4453622 | 0.75 | TSHR (0.43) | PPARDTSHRTP53TDP1CA12 | |
| Fosamine SCHEMBL8535758 | 0.75 | TSHR (0.43) | PPARDTSHRTP53TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101418013-A | Process for preparing intermediate ethyl methyl propionaldehyde phosphonate | UNIV NANKAI (CN) | 2009-04-29 | — | — | CN | claimed |
| CN-101418013-A | Process for preparing intermediate ethyl methyl propionaldehyde phosphonate | UNIV NANKAI (CN) | 2009-04-29 | — | — | CN | disclosed |
| US-7071344-B1 | Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments | SCHERING AG (DE) | 2006-07-04 | — | — | US | disclosed |
| US-20050227951-A1 | Verification of translation | STEINMEYER ANDREAS | 2005-10-13 | — | — | US | disclosed |
| US-20030018194-A1 | New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents | STEINMEYER ANDREAS (DE) | 2003-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227951-A1 | Verification of translation | CYP2R1, CYP24A1, VDR | PPARD 617/4885TSHR 1332/4885TP53 2921/4885 |
| US-20030018194-A1 | New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents | CYP2R1, CYP24A1, VDR | PPARD 94/4885TSHR 1101/4885TP53 4104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.